LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort

被引:30
作者
Bae, Ji Cheol [1 ]
Han, Ji Min [1 ]
Kwon, Sam [1 ]
Jee, Jae Hwan [2 ]
Yu, Tae Yang [3 ]
Lee, Moon Kyu [3 ]
Kim, Jae Hyeon [3 ,4 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Endocrinol & Metab,Dept Med, Chang Won 630723, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Hlth,Promot Ctr, Seoul 135710, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul 135710, South Korea
[4] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Clin Res Design & Evaluat, Seoul 135710, South Korea
关键词
Chronic kidney disease; Dyslipidemia; Estimated glomerular filtration rate; Triglycerides to high-density lipoprotein; cholesterol ratio; Low-density lipoprotein cholesterol; Apolipoprotein; PPAR-ALPHA AGONIST; INSULIN-RESISTANCE; RENAL DYSFUNCTION; LIPID-METABOLISM; PHENOTYPE-B; CHOLESTEROL; PROGRESSION; APOLIPOPROTEINS; ROSIGLITAZONE; NEPHROPATHY;
D O I
10.1016/j.atherosclerosis.2016.06.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: The objective of this study was to evaluate the ability of lipid variables to predict the development of chronic kidney disease (CKD). We investigated the longitudinal association between lipid profiles and incident CKD in a large apparently healthy cohort. Methods: A retrospective longitudinal analysis of 10,288 subjects who had participated in comprehensive health check-ups at least four times over a 7-year period was conducted. The risk of incident CKD associated with lipid variables was analyzed using adjusted hazard ratio (HR) for CKD per 1 standard deviation (SD) increase in lipid level. The development of CKD was defined as estimated glomerular filtration rate < 60 ml/min/1.73 m(2). Results: Over a mean follow-up of 56.5 +/- 14.3 months, 356 (3.5%) subjects developed CKD. The multivariate adjusted HRs for incident CKD per 1 SD increase in baseline lipid level were 1.29 (95% confidence interval [CI], 1.17-1.41) for triglycerides (TG), 0.77 (0.68-0.88) for high-density lipoprotein cholesterol (HDL-C), 1.22 (1.12-1.32) for the TG/HDL-C ratio, 0.82 (0.73-0.92) for the low-density lipoprotein cholesterol/apolipoprotein B (LDL-C/apoB) ratio, and 0.74 (0.66-0.83) for the HDL-C/apoA-1 ratio. No longitudinal association was found between incident CKD and baseline total cholesterol, LDL-C, non-HDL-C, the LDL-C/HDL-C ratio, apoB, apoA-I, or the apoB/apoA-I ratio. Conclusions: The LDL-C/apoB and HDL-C/apoA-1 ratios as well as TG and HDL-C concentrations independently predicted an increased risk for developing CKD. Our findings suggest that particle size of HDLs and LDLs may contribute to the development of CKD. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:170 / 176
页数:7
相关论文
共 41 条
[1]   Cellular lipid metabolism and the role of lipids in progressive renal disease [J].
Abrass, CK .
AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (01) :46-53
[2]   13. Diabetes Care in the Hospital [J].
不详 .
DIABETES CARE, 2016, 39 :S99-S104
[3]   Accuracy of the ratio of triglycerides to high-density lipoprotein cholesterol for predicting low-density lipoprotein cholesterol particle sizes, phenotype B, and particle concentrations among Asian Indians [J].
Bhalodkar, NC ;
Blum, S ;
Enas, EA .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (07) :1007-1009
[4]   Renal lipid metabolism and lipotoxicity [J].
Bobulescu, Ion Alexandru .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2010, 19 (04) :393-402
[5]   Ectopic lipid storage and insulin resistance: a harmful relationship [J].
Boren, J. ;
Taskinen, M. -R. ;
Olofsson, S. -O. ;
Levin, M. .
JOURNAL OF INTERNAL MEDICINE, 2013, 274 (01) :25-40
[6]   Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidylinositol 3-kinase/AKT-signaling pathway [J].
Bussolati, B ;
Deregibus, MC ;
Fonsato, V ;
Doublier, S ;
Spatola, T ;
Procida, S ;
Di Carlo, F ;
Camussi, G .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (07) :1936-1947
[7]   Atherogenic lipoprotein particles in atherosclerosis [J].
Carmena, R ;
Duriez, P ;
Fruchart, JC .
CIRCULATION, 2004, 109 (23) :2-7
[8]  
Cases A, 2005, KIDNEY INT, V68, P87
[9]   WY14,643, a peroxisome proliferator-activated receptor α (PPARα) agonist, improves hepatic and muscle steatosis and reverses insulin resistance in lipoatrophic A-ZIP/F-1 mice [J].
Chou, CJ ;
Haluzik, M ;
Gregory, C ;
Dietz, KR ;
Vinson, C ;
Gavrilova, O ;
Reitman, ML .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (27) :24484-24489
[10]   COMPARING THE AREAS UNDER 2 OR MORE CORRELATED RECEIVER OPERATING CHARACTERISTIC CURVES - A NONPARAMETRIC APPROACH [J].
DELONG, ER ;
DELONG, DM ;
CLARKEPEARSON, DI .
BIOMETRICS, 1988, 44 (03) :837-845